ResearcherUniversity of Bari Aldo MoroActive in the last 2 years

Alessia De Nisco

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3156-5018; OpenAlex author ID A5062701495. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Supplying LSD1 with FAD in pancreatic cancer: A matter of protein-protein interaction? Co-author DOI 10.1016/j.abb.2025.110291 ↗
Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLAD1 gene expression: the inhibitory effec… Co-author DOI 10.1111/febs.16881 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Maria Barile · 2 shared papers, 2023–2025 · strength 0.43
- Paper Supplying LSD1 with FAD in pancreatic cancer: A matter of protein-protein interaction? DOI 10.1016/j.abb.2025.110291 ↗
- Paper Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLA… DOI 10.1111/febs.16881 ↗
Rosa Angela Cardone · 2 shared papers, 2023–2025 · strength 0.43
- Paper Supplying LSD1 with FAD in pancreatic cancer: A matter of protein-protein interaction? DOI 10.1016/j.abb.2025.110291 ↗
- Paper Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLA… DOI 10.1111/febs.16881 ↗
Tiago M. A. Carvalho · 1 shared paper, 2023 · strength 0.17
- Paper Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLA… DOI 10.1111/febs.16881 ↗
Stephan J. Reshkin · 1 shared paper, 2023 · strength 0.17
- Paper Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLA… DOI 10.1111/febs.16881 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.